Skip to main content
Clinical Trials/NCT00636753
NCT00636753
Suspended
Not Applicable

Antipsychotics and Metabolic Syndrome

Glostrup University Hospital, Copenhagen1 site in 1 country60 target enrollmentSeptember 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
Glostrup University Hospital, Copenhagen
Enrollment
60
Locations
1
Status
Suspended
Last Updated
15 years ago

Overview

Brief Summary

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
July 2009
Last Updated
15 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Glostrup University Hospital, Copenhagen

Eligibility Criteria

Inclusion Criteria

  • Gender male
  • Age 18-45
  • Debut drug-naive schizophrenics,
  • Caucasians
  • Consent given to take part in the project

Exclusion Criteria

  • Compliance-problems
  • Major lung-/kidney/hart/lever disorders
  • Abuse of alcohol/drugs
  • Diabetes 1 and 2
  • Antihypertensive
  • Anticholesterol-reducing medication
  • Patients under duress

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials